Astellas announced that the FDA has designated isavuconazole as a Qualified Infectious Disease Product (QDIP) for the treatment of invasive candidiasis. Isavuconazole is an investigational once-daily ...
Astellas Pharma announced that the FDA has designated isavuconazole a Qualified Infectious Disease Product (QDIP) for the treatment of invasive aspergillosis. Isavuconazole is an investigational ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results